Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
2,648 INR | +0.78% | +0.82% | +2.72% |
05-14 | Nomura Upgrades Dr. Lal Pathlabs to Buy From Neutral, Adjusts Price Target to INR2,713 From INR2,505 | MT |
05-13 | Dr. Lal Pathlabs' Fiscal Q4 Consolidated Net Profit Rises; Share Up 6% | MT |
End-of-day quotes
Sector Medical & Diagnostic Laboratories
Capi. | Sales growth | Profitability | Finances | EV / Sales | P/E ratio | |
---|---|---|---|---|---|---|
2.63B | ||||||
7.76B | ||||||
4.33B | - | - | ||||
2.64B | ||||||
2.16B | ||||||
1.75B | - |